Hospitalization metrics associated with hospital-level variation in inferior vena cava filter utilization for patients with venous thromboembolism in the United States: Implications for quality of care

Vascular Medicine
Ming ChenJoshua Brown

Abstract

Variation in the use of inferior vena cava filters (IVCFs) across hospitals has been observed, suggesting differences in quality of care. Hospitalization metrics associated with venous thromboembolism (VTE) patients have not been compared based on IVCF utilization rates using a national sample. We conducted a descriptive retrospective study using the Nationwide Readmissions Database (NRD) to delineate the variability of hospitalization metrics across the hospital quartiles of IVCF utilization for VTE patients. The NRD included all-payer administrative inpatient records drawn from 22 states. Adult (≥ 18 years) patients with VTE hospitalizations with or without IVCF were identified from January 1, 2013 through December 31, 2014 and hospitals were divided into quartiles based on the IVCF utilization rate as a proportion of VTE patients. Primary outcome measures were observed rates of in-hospital mortality, 30-day all-cause readmissions and VTE-related readmissions, cost, and length of stay. Patient case-mix characteristics and hospital-level factors by hospital quartiles of IVCF utilization rates, were compared. Overall, 12.29% of VTE patients had IVCF placement, with IVCF utilization ranging from 0% to 46.84%. The highest quartil...Continue Reading

References

May 26, 2009·Journal of Vascular and Interventional Radiology : JVIR·John A KaufmanAnthony Venbrux
May 20, 2011·The American Journal of Medicine·Paul D SteinRussell D Hull
Oct 26, 2011·Journal of Vascular and Interventional Radiology : JVIR·Luis F AngelJohn Kaufman
Feb 9, 2012·The American Journal of Medicine·Paul D SteinGary L Willyerd
Apr 5, 2013·JAMA Internal Medicine·Richard H WhitePatrick S Romano
Nov 28, 2013·The American Journal of Medicine·Paul D Stein, Fadi Matta
Mar 1, 2014·Journal of the American College of Cardiology·Alfonso MurielUNKNOWN RIETE Investigators
May 14, 2014·JAMA Internal Medicine·Aaron L SchwartzJ Michael McWilliams
Aug 19, 2014·International Journal of Cardiology·Mohamad Alkhouli, Riyaz Bashir
Dec 3, 2014·The American Journal of Medicine·Toshiaki IsogaiKiyohide Fushimi
Apr 29, 2015·JAMA : the Journal of the American Medical Association·Patrick MismettiUNKNOWN PREPIC2 Study Group
Aug 23, 2016·Medical Care·Joshua D Brown, Jeffery C Talbert
Dec 4, 2016·Vascular Medicine·Immad SadiqUNKNOWN Submassive and Massive Pulmonary Embolism Treatment with Ultrasound AcceleraTed ThromboLysis ThErapy (SEATTLE II) Investigat
Sep 6, 2017·Journal of the American Heart Association·Joshua D BrownJeffery C Talbert

❮ Previous
Next ❯

Software Mentioned

JMP
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.